FDA advisers vote in support of Paxlovid approval for Covid-19 treatment in high-risk adults

Advisers to the US Food and Drug Administration voted 16-1 on Thursday in support of full approval of Paxlovid, stating that the benefits outweigh any risks of the drug for treatment of mild to moderate Covid-19 in adults who are at high risk for severe disease, including hospitalization and death.

(SOURCE) https://www.cnn.com/2023/03/16/health/fda-committee-paxlovid-approval/index.html


Related Posts

Opinion: This may be the only way to stop social media from harming our kids

Tech executives could face the prospect of time behind bars in Britain if...

‘It’s all a lie’: Russians are trapped in Putin’s parallel universe. But some want out

• Live Updates: Zelensky fires Ukraine’s commander of joint forces • DeSantis’ stance...

Leave a Comment

Your email address will not be published. Required fields are marked *

Add Comment *

Name *

Email *